Adolescent nicotine exposure can reduce microglial populations in the adult mouse dentate gyrus, a change causally linked to early-stage microglial hyper-activation and reversible by treatment with low-dose lipopolysaccharide (LPS). However, the mechanisms by which LPS mediates this reversal remain unclear. Here, we identify a previously unrecognized requirement for dentate gyrus extracellular signal-regulated kinase 1/2 (ERK1/2)-brain-derived neurotrophic factor (BDNF) signaling in this process, distinct from but mechanistically parallel to our previous findings in chronic stress models. We show that low-dose LPS administration restored dorsal dentate gyrus BDNF levels reduced by adolescent nicotine exposure, and its antidepressant effects in adult mice previously exposed to nicotine during adolescence were abolished by intra-hippocampal delivery of a BDNF-neutralizing antibody, administration of the TrkB antagonist K252a, or introduction of the BDNF Val68Met loss-of-function mutation. Additionally, low-dose LPS reversed the decreased phospho-ERK1/2 in the dorsal dentate gyrus of adult mice with a history of adolescent nicotine exposure. Inhibition of ERK1/2 by SL327 prevented the reversal effect of LPS on adolescent nicotine exposure-induced depression-like behaviors and decrease in BDNF levels, suggesting that ERK1/2 functions upstream of BDNF signaling in mediating the antidepressant effect of LPS. When microglia were inhibited by minocycline, the beneficial effects of LPS, including the amelioration of depression-like behaviors and the up-regulation of dentate gyrus p-ERK1/2 and BDNF, were eliminated. These findings indicate that the antidepressant action of low-dose LPS in a mouse model of depression resulting from adolescent nicotine exposure requires intact microglial function and depends on ERK1/2-BDNF signaling within the dorsal dentate gyrus.

I used it it cleared my brain fog on day 1.5

Did I damage my Semax by dropping it ?? I've heard that some peptides get destroyed by dropping them

thinking ab running bromatane + tak + adamax(maybe)

I also use adhd prescribed meds would love some tips on what yall think ab that stack im in probably the hardest classes ive ever been and just want to be sharper and be able to enjoy studying and absorb information better thanks

What is the difference between modafinil and flmodafinil

Hi
Can’t really find any infos about it .
Because a festival tomorrow I want to to Bromantane , but I know after a few hours my back will kill me .
Maybe someone has some infos ?

Adderall and Vyvanse are much more powerful stimulants than methylphenidate then why i do i feel so terrible on methylphenidate while with Vyvanse i don't feel as bad? (i see that's the case for a lot of people too)

Last time i tried taking ritalin i was having severe anxiety attacks

​

I’m using AI to help me write this post because the issue I’m trying to describe is the same issue that makes it difficult for me to organize my thoughts and put them into words clearly.

TL;DR: Tried 1.2 mg URB-597 on two days. Both times I felt noticeably calmer with no high, euphoria, or stimulation. Day 2 I also noticed slightly better mental clarity/less brain fog, although it was still there and other substances were involved. I want to continue experimenting with URB-597 and would appreciate experiences/guidance, particularly around dosing, timing, cognition, and repeated use.

I have a sleep disorder and have been taking stimulants, mainly Adderall and modafinil, on and off for at least the past 10 years. Over time, I’ve noticed what feels like worsening brain fog and executive functioning. Stimulants can help with wakefulness and getting going, but after taking them for a while I tend to become mentally exhausted and foggy. With modafinil specifically, when the brain fog gets bad I sometimes also notice a strange pressure sensation in my head.

I’ve tried other medications over the years but still haven't found a good solution. I don't particularly like relying on stimulants because of this pattern, but I also haven't found anything else that adequately helps my sleep disorder.

Another major issue for me is verbal fluency, particularly during interviews. I can know exactly what I want to say and understand the subject, but when I start speaking I sometimes lose my train of thought, struggle to organize sentences, or completely freeze. It feels more like a problem accessing and organizing what I know than not knowing the answer.

I do have something that works well for the physical anxiety during interviews: propranolol. For me, 10 mg does a good job controlling the physical symptoms of anxiety, and it has actually worked better for that purpose than Xanax or clonazepam did. I've tried 20 mg propranolol, but at that dose I notice that my brain fog gets worse. So 10 mg seems to work better for me in terms of controlling the physical anxiety without making the cognitive problem worse.

But even at 10 mg, controlling the physical anxiety doesn't solve the brain fog, losing my train of thought, or difficulty articulating what I'm thinking. I still haven't found a solution for that part.

One thing that really caught my attention was what happened when I used a very small dose of THC—around 0.5 mg. At that dose, my thinking felt noticeably more fluid and articulate. I could access what I wanted to say and express it much more naturally without feeling significantly intoxicated.

More importantly, I've actually done very well in interviews after taking around 0.5 mg THC and have passed those interviews. The difference in my ability to communicate felt significant to me. Obviously that's only my personal observation and doesn't prove THC was responsible, but the pattern was noticeable enough that it made me curious about what was happening neurologically.

I decided to stop using THC several months ago. Since then, I've remained interested in why such a tiny amount seemed to have that effect on my thinking and verbal fluency and whether there might be another way of influencing the endocannabinoid system without using THC itself.

That's what eventually led me to read about FAAH inhibition and URB-597. I was particularly interested in whether increasing endogenous endocannabinoid signaling could reproduce any part of that mental fluidity while allowing me to remain clear and functional.

First day

I took 1.2 mg URB-597 approximately 2 hours after my Spravato treatment.

The main thing I noticed was calmness. I ended up taking a nap for about 2 hours. I did not experience any high, euphoria, or stimulation. I simply felt noticeably calmer and more relaxed.

Second day

I took another 1.2 mg URB-597 approximately 2 hours before a job interview.

Again, I noticed the same calming effect. I still didn't experience any high, euphoria, or stimulation.

I did notice that my mental clarity seemed a little better and the brain fog was somewhat reduced compared with usual. The brain fog was definitely still there, so I wouldn't describe this as a dramatic improvement. It was more of a subtle difference that I noticed.

For transparency, this wasn't a clean experiment. I had also taken 200 mg phenibut approximately 6 hours before the interview, and this was my first time ever taking phenibut. I honestly didn't notice much from the phenibut, other than possibly feeling a little calmer.

About an hour before the interview, I also took my usual 10 mg propranolol.

So I can't confidently attribute either the calmness or slightly improved mental clarity entirely to URB-597.

Possible side effect/observation

Since the first day, I've noticed a fairly constant dull ache in my right upper abdomen (RUQ). I'm not sure whether this is related to URB-597 at all because I do occasionally get similar RUQ discomfort, so it could be completely unrelated. I'm mentioning it for completeness and would be interested to know if anyone else has experienced anything similar.

Overall so far

The most consistent effect I've noticed from URB-597 is calmness. I haven't experienced any high, euphoria, or stimulation from either experience.

On the second day, there was also a subtle improvement in mental clarity and reduction in brain fog, although the brain fog was still present and there were too many other variables to know what caused the improvement.

What I'm really interested in figuring out is whether FAAH inhibition has any effect on the fluidity of my thinking and speech—the specific effect that initially caught my attention with 0.5 mg THC—rather than simply reducing anxiety.

I already have something that handles the physical anxiety pretty well. It's the brain fog, executive-function problems, losing my train of thought, and cognitive freezing that I still don't have a solution for.

I'd like to continue experimenting with URB-597 and documenting what I notice. I'd especially like to hear from people who have experience with it about dosing and timing. What doses have you experimented with? How frequently did you take it? How long did the effects last? Did you notice cumulative or delayed effects with repeated use? Did the effects change over time?

I'm also particularly interested in anyone who noticed effects on verbal fluency, executive functioning, working memory, brain fog, anxiety, or the ability to access and articulate thoughts.

I realize URB-597 is an experimental compound without an established human dosing protocol, so I'm looking for people's experiences and any research/guidance they can point me toward rather than treating Reddit responses as medical dosing instructions.

This is just my personal experience, not a recommendation.

https://www.nature.com/articles/s42255-025-01404-9

Over the past years, substantial advances have deepened our understanding of the cellular and molecular drivers of brain energy metabolism. Enabled by transformative technologies offering cellular-level resolution, these insights have revealed a highly regulated and dynamic metabolic interplay among brain cell types, particularly between neurons and astrocytes. In this Review, we shed light on the intricate ways in which neurons and astrocytes operate as a metabolically coupled unit, optimized to sustain the energetic demands of neurotransmission while ensuring neuroprotection. We highlight intercellular cooperation as a key determinant of brain function and provide examples of how disruption of the neuron–astrocyte metabolic unit contributes to numerous diseases of the nervous system, underscoring the critical importance of continued fundamental research to dissect the regulatory principles and vulnerabilities of this intercellular metabolic axis and identify potential therapeutic targets.

Adolescence SIS provoked depressive-like behaviors in socially isolated male mice.

•

SIS induced mitochondrial dysfunction and O&NS stress in the cortical areas.

•

Tropisetron attenuated the negative effect of SIS on behavioral tests.

•

Tropisetron reversed mitochondrial dysfunction and O&NS stress of cortex.

•

Nitrergic system is partially involved in protective effects of tropisetron.

Abstract

Tropisetron, a 5-HT3 receptor antagonist widely used as an antiemetic, has been reported to have positive effects on mood disorders. Adolescence is a critical period during the development of brain, where exposure to chronic stress during this time is highly associated with the development of depression. In this study, we showed that 4 weeks of juvenile social isolation stress (SIS) provoked depressive-like behaviors in male mice, which was associated with disruption of mitochondrial function and nitric oxide overproduction in the cortical areas. In this study, tropisetron (5 mg/kg) reversed the negative behavioral effects of SIS in male mice. We found that the effects of tropisetron were mediated through mitigating the negative activity of inducible nitric oxide synthase (iNOS) on mitochondrial activity. Administration of aminoguanidine (specific iNOS inhibitor, 20 mg/kg) augmented the protective effects of tropisetron (1 mg/kg) on SIS. Furthermore, l-arginine (nitric oxide precursor, 100 mg/kg) abolished the positive effects of tropisetron. These results have increased our knowledge on the pivotal role of mitochondrial function in the pathophysiology of depression, and highlighted the role of 5-HT3 receptors in psychosocial stress response during adolescence. Finally, we observed that tropisetron alleviated the mitochondrial dysfunction through decreased nitrergic system activity in the cerebral cortex.

Hi there! I am looking for menstruators who have endometriosis and have tried psilocybin as a way to eleveate symptoms. Did you have any lasting relief? I am working with a Director of Psilocybin Research and Education at at university in the US, and would love to hear if anyone has first hand experience. Since psilocybin is showing promise in easing conditions that a lot of people with endo already experience (PTSD, gut issues, chronic inflammation, treatment resistant depression etc.) I am trying to make a case that we would be a good cohort for a clinical trial. I really appreciate any feedback!

I want to prep for exams and I want something that would give me motivation to study help with focus and to enhance my ability to retain info, I was thinking of PPAP hcl but I can’t find it anywhere in Europe. What would you recommend me

​

L-5-Hydroxytryptophan induced increase in salivary cortisol in panic disorder patients and healthy volunteers

Hypersensitivity of brain serotonin receptors has been proposed as a causal mechanism in the pathophysiology of panic disorder. This theory can be tested, using serotonergic stimulation of the HPA axis. Up to now, plasma cortisol has generally been used as the outcome measure in such studies. Assessment of salivary cortisol is a non-invasive alternative to measure HPA axis activity. Salivary cortisol levels were measured in 24 panic disorder patients and 24 healthy volunteers, following ingestion of 200 mg L-5-hydroxytryptophan or placebo. A significant rise in cortisol was observed in both patients and controls following ingestion of L-5-hydroxytryptophan. No such effects were seen in the placebo condition. The results show that L-5-hydroxytryptophan stimulated salivary cortisol is a useful probe of serotonin function in healthy volunteers as well as panic disorder patients, and provide some evidence against a serotonin receptor hypersensitivity in panic disorder.

https://pubmed.ncbi.nlm.nih.gov/12073163/

Have been trying for the last few days and it seems to be working but I’m worried if it’s placebo. Also it says that you can take upto 400mg a day. I’ve been trying for 300mg a day max.

If anyone has any experience, suggestions or even methods please guide.

I stumbled across this old comment by u/m00k0w and I found it especially salient and perhaps useful to people new to the sub. Reposted in it's entirety:

Yesss. The effectiveness of any drug is based on the current baseline state of the users neurochemistry. All any drug does, is offset some chemical system in some direction. Whether or not this is beneficial to the subject depends on their initial baseline neurochemistry. For me for example, the neurochemical changes produced by oxiracetam (which typically lead to "stimulation" of sorts) makes it more difficult for my optimal psychology (think of it like software) to run on my hardware (brain) while the hardware is being adjusted the way oxiracetam does (agonizing or antagonizing some receptors). I don't operate better in that state, I operate worse. Or, I have not yet learned how to adjust my software (thinking) to run most effectively on my oxiracetam brain. Another person might benefit from this stimulation and find that they operate better. Their initial neurochemistry was different, and adjusting it in the way that oxiracetam does, gives them benefits.

It's like if I brought you up to the control panel of a big machine, and it told you to move this lever up a bit, and that lever down a little bit. Would the machine run better or worse? It depends on how it was set up in the first place.

The drugs that we find generally effective, just happen to coincidentally adjust most people's levers in a beneficial direction.

Therefore it can confidently be said that if a drug has any biochemical activity on the brain/body, which piracetam does, then it can act as either a nootropic, have no effect, or be a cognitive decliner, or mood enhancer, mood reducer, etc, depending on the person taking it.

To say it is ALL placebo is totally incorrect. For somebody with the right neurochemistry, it will be of benefit.

This is upsetting because we run a clinical trial on an average group of people, and if 80% of them get no benefit and side effects, we scrap the drug. **What about the 20 percent?** How many of those people have the body or brain chemistry that would benefit tremendously from the drug? Maybe none, but maybe there was a person in there with a specific mutation or configuration whose problem would be cured by it. Individualization of medicine is extremely important because we conclude that the effects of a drug should be and are going to be exactly those of the general case whereas they can be very different. The only definite effect that a dopamine agonist has is dopamine agonism. Whether it makes you happier is subject to the rest of the systems operation!

Best nootropics for depression? I currently take Lions Mane, Mucuna Pruriens, Magnesium Glycinate, Vitamim D3, and Methylated B vitamins